Skip to main content

Search

Clear
Filter by Type
Filter by Topics
Filter by Symptoms & Conditions
Filter by Year
Good News for Physical Therapy: 4 Promising Developments on Capitol Hill

Aug 8, 2022/Roundup

Advocacy by APTA and its members is paying off in some key ways.

Final FY 2023 SNF Rule: An Advocacy Win Brightens the Payment Picture

Aug 29, 2022/Review

CMS took the advice of APTA and others, and made some additional adjustments of its own. The result: a welcome 2.7% increase.

5 Questions for the Public Member of the APTA Board of Directors

Jul 27, 2022/Interview

Hear from the first public member of the APTA Board of Directors.

Lawmakers Urge Veterans Affairs to Raise Pay, Expand Roles of PTs and PTAs

Jul 5, 2022/News

In an advocacy win, APTA-supported recommendations aimed at increasing veterans' access to PTs and PTAs are now part of a spending bill.

HHS Secretary to APTA: No Time for Complacency at this Moment in Health Care

Aug 17, 2022/News

In remarks that ranged from the fee schedule to long COVID, Xavier Becerra stressed the role PTs and PTAs can play in fostering change.

Get Ready for the 30th Annual National Physical Therapy Month

Sep 6, 2022/Article

It’s time to plan your celebration of the profession — and the important role you play in it.

APTA Lecture Series Returns With Focus on Lower Extremity Tendinopathy

Jun 29, 2022/News

One of the country's leading PT researchers on the condition will provide case-based insights.

APTA 2022 House of Delegates Election Results Announced

Jul 30, 2022/News

The following members were elected or re-elected to APTA's Board of Directors and Nominating Committee on July 30.

The State of the Profession: Two APTA Profile Reports Set the Scene

Jul 18, 2023/News

Data analysis also demonstrates that APTA membership is a good reflection of the profession overall.

APTA Chapters Fuel State-Level Wins

Jul 24, 2023/Roundup

Growing participation in the PT Compact, expanded direct access, ability to order imaging, limits on prior authorization, and more.